Following FDA approval of the AspireSR® generator for the VNS Therapy® system in June 2015, more than a thousand patients with drug-resistant epilepsy across the United States have received this new treatment option. Many of these patients are experiencing benefits which have positively impacted their lives – and are sharing their stories during Epilepsy Awareness Month with the hope of encouraging others to seek new treatments for drug-resistant epilepsy. Numerous hospitals nationwide have begun providing the AspireSR device to patients with drug-resistant epilepsy – a condition that affects as many as one-third of people with epilepsy, causing them to have seizures in spite of treatment with antiepileptic medications.
The VNS Therapy system is a minimally invasive option in which a medical device is placed under the skin in the upper chest area during an outpatient procedure. The device sends mild electrical pulses through the vagus nerve to areas of the brain known to be associated with seizures. The new AspireSR generator takes the VNS Therapy technology a step further – detecting relative heart-rate increases that are often associated with seizures in people with epilepsy and providing responsive stimulation in an attempt to stop and shorten seizures and improve recovery.
To view the multimedia release go to:
http://www.multivu.com/players/English/7651751-livanova-aspiresr-treatment/
Surgeons at Gundersen Lutheran Heart Institute in La Crosse, Wis., are using an innovative technique, called minimally invasive coronary surgery (MICS), to perform multiple heart bypasses through a small incision. That means surgeons do not have to
InSightec Ltd, the leader in magnetic resonance imaging (MRI)-guided Focused Ultrasound therapy, announced that the U.S. Food and Drug Administration (FDA) has approved ExAblate® MRI-guided focused ultrasound as a therapy to treat pain from bone metastases in patients who do not respond or cannot undergo radiation treatment for their pain. This is the second FDA approval for ExAblate, which has been used widely since it was approved in 2004 as a non-invasive, outpatient, therapy for uterine fibroids.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56632-insightec-fda-approves-exablate
Today from 7 a.m. to 12 p.m. (Pacific Time-US), surgeons from the Swedish Orthopedic Institute will offer people the opportunity to see a knee surgery in a way that has rarely been done before by a health-care system. Sean Toomey, M.D., an orthopedic surgeon, will repair the knee of a 70-year-old male patient, while it is streamed live online. The webcast will be moderated by orthopedic surgeon James Crutcher, M.D. The patient, identified by Dr. Toomey as a candidate for a partial knee replacement procedure, volunteered and consented to have his minimally invasive knee resurfacing surgery streamed on the Internet.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/swedish/49172/
It's no surprise that about 1 in 8 women in the United States will develop invasive breast cancer over the course of her lifetime. In fact, for women in the U.S., breast cancer death rates are higher than those for any other cancer, besides lung cancer. In honor of Breast Cancer Awareness Month in October, our national healthcare expert is here to discuss educating and empowering women to take charge of their own breast health.
Prem Rabindranauth, MD, a heart surgeon at Gundersen Lutheran Health System in La Crosse, Wis., is using an exciting technique, called minimally invasive coronary surgery (MICS), to perform heart bypass surgery. To perform MICS, a very small three-inch cut is made between the ribs instead of the long cut through the breast bone that is needed with traditional open heart surgery. This means less pain and blood loss, fewer risks for problems, shorter hospital stays and quicker healing time.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/gundluth/49124/
Today, Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and non-invasive skin tightening and a global market leader in aesthetic treatments, announced the arrival of its groundbreaking Liposonix technology in the United States and Canada. Using advanced high-intensity focused ultrasound (HIFU) technology, Liposonix is a non-surgical permanent fat reduction procedure that has been clinically shown to slim down the waistline by one pant or dress size without surgery or downtime. It is indicated for non-invasive waist circumference reduction for use on both the abdomen and love handles.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54037-solta-liposonix-custom-contouring-waistline-fat-reduction
Two of the most advanced tools for precise, radiotherapy-based treatment are now under one roof in Seattle. Swedish Medical Center this month became the first facility in the Pacific Northwest – and one of only a handful in North America – to open a unit that incorporates both CyberKnife and Gamma Knife technologies. The 3,950-square-foot Swedish Radiosurgery Center, formerly known as the Seattle CyberKnife Center, is located on the
Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today celebrates 10 years of the availability and success of its NovaSure endometrial ablation system. Since 2001, more than one and a half million women have been treated with the NovaSure system to reduce or eliminate their heavy periods, without the need to undergo hysterectomy. The NovaSure procedure is a one-time, five-minute procedure that can be performed in the doctor’s office with very minimal recovery time.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/hologic/50096/
Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market and manufacturer of the industry's three premier brands: Thermage®, Fraxel®, and Isolaz®, is pleased to announce that it has partnered with PGA TOUR golfer Scott McCarron to raise awareness about skin protection and the Fraxel re:store® laser treatment. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin, including the removal of actinic keratoses (AK’s ) — a precancerous skin condition caused by sun exposure. Fraxel re:store treatment provides superior results for AKs on the face or other areas of the body displaying the signs of photodamage.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/solta/45388/
Mark Saxton, MD, pediatric surgeon at Gundersen Lutheran Health System in La Crosse, Wis., is performing a minimally invasive surgery to correct pectus excavatum (sunken chest) in adults.
“Sunken chest is a birth defect characterized by a sunken sternum or breastbone,” explains Dr. Saxton. “The deformity tends to worsen until the patient is full grown and will not improve with age. It is caused by extreme growth of cartilage that connects each rib to the sternum. This causes the sternum to buckle in towards the spine.”
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/gundluth/43811/
Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and non-invasive skin tightening, is pleased to serve as a returning sponsor of the Fresh Express Classic™ at TPC Stonebrae. A Nationwide Tour™ event, the Fresh Express Classic will be held from Tuesday, April 12 through Sunday, April 17, at one of best new golf courses in the U.S., with breathtaking views of the San Francisco Bay. The tournament will include a series of on-site events for fans, including a pro-am led by Pro Football Hall of Fame member Jerry Rice to raise more than $250,000 for Bay Area charities. The event will be televised nationally on The Golf Channel.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/fraxel/49682/
